Search

everythinglearnresearchcommunity

for

Search:↓

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Age, smoking, and lower BMI increase facial wrinkles; men wrinkle more than women, except in old age; pale skin and certain hormonal factors can protect against wrinkles.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Using only hyperandrogenism to diagnose PCOS can lead to overdiagnosis.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

PCOS affects many women, causing various symptoms and health risks, and is managed through lifestyle changes, medication, and support groups.

Higher testosterone and DHEA-S levels may be linked to male pattern baldness.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Both finasteride and drospirenone effectively manage PCOS symptoms, but drospirenone is more effective in reducing ovarian volume and androgen levels.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.